Guidelines for submitting a nutritional product to the ACBS
Information and advice on submitting a nutritional product to the Advisory Committee for Borderline Substances (ACBS).
Applies to England
Documents
Details
This set of documents contains supporting information for use in submitting a nutritional product for consideration by the Advisory Committee for Borderline Substances (ACBS). This includes:
- how nutritional products are categorised by the ACBS
- evidence required for applications
- relevant nutritional legislation
The documents can be used when filling out the nutritional products application form.
Updates to this page
Published 12 April 2019Last updated 1 February 2024 + show all updates
-
Removed 'Appendix 2.1: evidence required for type 3 applications' because this document no longer applies.
-
In section 2.4 of 'Guidance notes for completing an application form for a nutritional product' the MHRA email address has been amended.
-
Appendix 5 has been updated with new guidance on acceptability studies for inherited metabolic disorders.
-
Added appendix 8: the scheduling of product applications to an ACBS meeting agenda
-
Added guidance notes for completing an application form for a nutritional product.
-
Updated the definitions for type 2 and type 3 applications, in the attachment 'Appendix 2: types of application'.
-
Updated to remove the requirement to submit a type 3 application for changes to (i) a product’s shelf life and (ii) the location of manufacture.
-
First published.